维他奶後人罗琪茵斥1.2亿元增持思捷(00330.HK) 成最大股东
联交所权益披露显示,资深投资者庄友坚妻子、维他奶(00345.HK)罗氏家族後人罗琪茵上周五(3日)於场外增持思捷(00330.HK)1.5亿股,每股平均价0.8029元,涉资约1.2亿元,其持股自4.93%提升至12.89%,成为思捷最大股东,取代由思捷创办人邢李(火原)女儿邢嘉倩、邢爱林及邢言爱共同持有之Total Market Limited,其持股为11.22%。
思捷(00330.HK)今早(9日)起停牌,涉公布内幕消息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.